Browse diseases

…k (HR=0.677, 95% CI =0.638 to 0.719, p<0.001), particularly for Alzheimer’s disease (HR=0.643, 95% CI=0.576 to 0.716, p<0.001), with no significant…

…with MCI and mild AD.Methods and analysis People with MCI, mild AD and healthy controls will be assessed for cognitive deficits us…

…logic burden was quantified using a 10-item index of markers of Alzheimer’s disease and mixed brain pathology. Accelerated failure time models esti…

…ion is associated with increased risks of vascular dementia and Alzheimer’s disease. Preexisting cerebrovascular pathologies increase susceptibilit…

…the US are to have easier initial access to a new drug to treat Alzheimer’s disease thanks to a decision by the US Food and Drug Administration (FD…

… underwent SS-OCTA and structural MRI (S-MRI). Individuals with Alzheimer’s disease were excluded based on plasma biomarkers. Participants were spl…

…on-affective psychosis and depression may help reduce long-term dementia risk and inform prevention strategies.…

…healthcare access.Conclusions This model could support scalable AD risk screening using routinely collected data, but external val…

…d South Africa. Leading APMP-attributable burdens in BRICS were ischaemic heart disease, chronic obstructive pulmonary disease and intracerebral haemor…

…Introduction Alzheimer’s disease (AD) is a neurodegenerative disorder that severely hinders qual…

…, valacyclovir, famciclovir.Main outcome measures Initiation of AD drug treatment, defined as at least two prescriptions for rivas…

…DA) for mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD) in the past 5 years, all amyloid-beta targeting monoclonal…